Abbyy Tech Helps FDA Analyze Drug Safety Reports
The Food and Drug Administration uses Abbyy's artificial intelligence-based information technology platform to simplify the process of analyzing data from pre-marketing clinical trial safety reports on experimental drugs, GCN reported Wednesday. “We found that we can just drop 100,000 files in, have them process over the course of a week and almost all of them were recognized,†Justin Scott, senior business informatics officer at the FDA, was quoted as saying.